Abstract
The local invasion and metastatic spread of tumor cells throughout the body is one of the primary concerns of the oncologist. If all tumors were confined within a defined space, most neoplasms could be removed and subsequently cured with the surgeon’s scalpel. However, this is not the case within the scope of cancer biology. Some neoplasms are highly metastatic (melanoma), while others are rarely metastatic (brain tumors), but given enough time and/or negligence most tumors will spread to distant sites. The intent of this series is to understand the mechanisms that tumor cells use to invade, disseminate and form viable metastatic colonies as well as discuss potential therapies for metastatic disease. This chapter will address the role of the matrix metalloproteinases (MMPs) and their inhibitors in the process of tumor progression, invasion, and metastasis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albini A, Fontanini G, Masiello L, Tacchetti C, Bigini D, Luzzi P, Noonan DM, StetlerStevenson WG (1994) Angiogenic potential in vivo by Kaposi’s sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2. AIDS 8: 1237–1244.
Andreasen PA, Kristensen P, Lund LR, DanØ K (1990) Urokinase-type plasminogen activator is increased in the involuting ventral prostate of castrated rats. Endocrinology 126: 2567–2576.
Anichini E, Fibbi G, Pucci M, Caldini R, Chevanne M, Del Rosso M (1994) Production of second messengers following chemotactic and mitogenic urokinase-receptor interaction in human fibroblasts and mouse fibroblasts transfected with human urokinase receptor. Exp Cell Res 231: 438–448.
Apte SS, Hayashi K, Seldin MF, Mattei MG, Hayashi M, Olsen BR (1994) Gene encoding a novel murine tissue inhibitor of metalloproteinases (TIMP), TIMP-3, is expressed in developing mouse epithelia, cartilage, and muscle, and is located on mouse chromosome 10. Dev Dyn 200: 177–197.
Azzam HS, Arand G, Lippman ME, Thompson EW (1993) Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production. J Natl Cancer Inst 85: 1758–1764.
Banyai L, Tordai H, Patthy L (1994) The gelatin-binding site of human 72 kDa type IV collagenase (gelatinase A). Biochem J 298: 403–407.
Baragi VM, Fliszar CJ, Conroy MC, Ye QZ, Shipley JM, Welgus HG (1994) Contribution of the C-terminal domain of metalloproteinases to binding by tissue inhibitor of metalloproteinases. C-terminal truncated stromelysin and matrilysin exhibit equally compromised binding affinities as compared to full-length stromelysin. J Biol Chem 269: 12692–12697.
Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chenard MP, Rio MC, Chambon P (1990) A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348: 699–704
Basset P, Wolf C, Chambon P (1993) Expression of the stromelysin-3 gene in fibroblastic cells of invasive carcinomas of the breast and other human tissues: a review. Breast Cancer Res Treat 24: 185–193
Basset P, Wolf C, Rouyer N, Bellocq J-P, Rio M-C, Chambon P (1994) Stromelysin-3 in stromal tissue as a control factor in breast cancer behavior. Cancer Suppl 74: 1045–1049.
Bigg HF, Clark IM, Cawston TE (1994) Fragments of human fibroblast collagenase: Interaction with metalloproteinase inhibitors and substrates. Biochim Biophys Acta 1208: 157–165.
Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA (1993) Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4: 197–250.
Bode W, Reinemer P, Huber R, Kleine T, Schnierer S, Tschesche H (1994) The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity. EMBO J 13: 1263–1269
Boring CC, Squires TS, Tong T (1993) Cancer Statistics, 1993. CA Cancer J Clin 43: 7–26.
Boudreau N, Sympson CJ, Werb Z, Bissel MJ (1995) Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267: 891–893.
Bresnahan PA, Leduc R, Thomas L, Thorner J, Gibson HL, Brake AJ, Barr PJ, Thomas G (1990) Human fur gene encodes a yeast KEX2-like endoprotease that cleaves pro-beta-NGF in vivo. J Cell Biol 111: 2851–2859
Brown PD, Bloxidge RE, Anderson E, Howell A (1993a) Expression of activated gelatinase in human invasive breast carcinoma. Clin Exp Metastasis 11: 183–189
Brown PD, Bloxidge RE, Stuart NS, Gatter KC, Carmichael J (1993b) Association between expression of activated 72-kilodalton gelatinase and tumor spread in nonsmall-cell lung carcinoma. J Natl Cancer Inst 85: 574–578
Campo E, Merino MJ, Liotta L, Neumann R, Stetler-Stevenson W (1992) Distribution of the 72-kd type IV collagenase in nonneoplastic and neoplastic thyroid tissue. Hum Pathol 23: 1395–1401
Cao J, Sato H, Takino T, Seiki M (1995) The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for progelatinase A activation. J Biol Chem 270: 801–805
Chin JR, Murphy G, Werb Z (1985) Stromelysin, a connective tissue-degrading metalloendopeptidase secreted by stimulated rabbit synovial fibroblasts in parallel with collagenase. Biosynthesis, isolation, characterization, and substrates. J Biol Chem 260: 12367–12376
Collier IE, Smith J, Kronberger A, Bauer EA, Wilhelm SM, Eisen AZ, Goldberg GI (1988) The structure of the human skin fibroblast collagenase gene. J Biol Chem 263: 10711–10713
Crabbe T, Smith B, O’Connell J, Docherty A (1994) Human progelatinase A can be activated by matrilysin. FEBS Lett 345: 14–16.
Damsky CH, Werb Z (1992) Signal transduction by integrin receptors for extracellular matrix: cooperative processing of extracellular information. Curr Opin Cell Biol 4: 772–781
DeClerck YA, Yean TD, Chan D, Shimada H, Langley KE (1991) Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor. Cancer Res 51: 2151–2157
DeClerck YA, Perez N, Shimada H, Boone TC, Langley KE, Taylor SM (1992) Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 52: 701–708
Del Rosso M, Anichini E, Pedersen N, Blasi F, Fibbi G, Pucci M, Ruggiero M (1993) Urokinase-urokinase receptor interaction: non-mitogenic signal transduction in human epidermal cells. Biochem Biophys Res Commun 190: 347–352
Eeckhout Y, Vaes G (1977) Further studies on the activation of procollagenase, the latent precursor of bone collagenase: effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation. Biochem J 166: 21–29
Engel G, Heselmeyer K, Auer G, Bäckdahl M, Eriksson E, Linder S (1994) Correlation between stromelysin-3 mRNA level and outcome of human breast cancer. Int J Cancer 58: 830–835
Fearon E, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759–767
Fidler IJ (1991) Cancer metastasis. Br Med Bull 47: 157–177
Fisher C, Gilbertson-Beadling S, Powers EA, Petzold G, Poorman R, Mitchell MA (1994) Interstitial collagenase is required for angiogenesis in vitro. Dev Biol 162: 499–510.
Fosang AJ, Neame PJ, Hardingham TE, Murphy G, Hamilton JA (1991) Cleavage of cartilage proteoglycan between G1 and G2 domains by stromelysins. J Biol Chem 266: 15579–15582.
Freije JM, Diez-Itza I, Balbin M, Sanchez LM, Blasco R, Tolivia J, Lopez-Otin C (1994) Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 269: 16766–16773
Gaire M, Magbanua Z, McDonnell S, McNeil L, Lovett DH, Matrisian LM (1994) Structure and expression of the human gene for the matrix metalloproteinase matrilysin. J Biol Chem 269: 2032–2040
Goldberg G, Wilhelm S, Kronberger A, Bauer E, Grant G, Eisen A (1986) Human fibroblast collagenase; complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem 261: 6600–6605
Gutmann A, Wasylyk B (1990) The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO J 9: 2241–2246
Hähnel E, Harvey JM, Joyce R, Robbins PD, Sterrett GF, Hähnel R (1993) Stromelysin-3 expression in breast cancer biopsies: clinico-pathological correlations. Int J Cancer 55: 771–774
Hamdy FC, Fadlon EJ, Cottam D, Lawry J, Thurrell W, Silcocks PB, Anderson JB, Williams JL, Rees RC (1994) Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia. Br J Cancer 69: 177–182
Hanks GE, Myers CE, Scardino PT (1993) Cancer of the prostate. In: DeVita VTJ, Hellman S, Rosenberg SA (eds) Cancer: principles and practice, 4th edn. Lippincott, Philadelphia, pp 1073–1113
Harris JR, Morrow M, Bonadonna G (1993) Cancer of the breast. In: DeVita VTJ, Hellman S, Rosenberg SA (eds) Cancer: principles and practice, 4th edn. Lippincott, Philadelphia, pp 1264–1332
Hasty KA, Jeffery JJ, Hibbs MS, Welgus HG (1987) The collagen substrate specificity of human neutrophil collagenase. J Biol Chem 262: 10048–10052
Hasty KA, Pourmotabbed TF, Goldberg GI, Thompson JP, Spinella DG, Stevens RM, Mainardi CL (1990) Human neutrophil collagenase: a distinct gene product with homology to other matrix metalloproteinases. J Biol Chem 265: 11421–11424
He CS, Wilhelm SM, Pentland AP, Marmer BL, Grant GA, Eisen AZ, Goldberg Gl (1989) Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sci USA 86: 2632–2636
Hirose T, Patterson C, Pourmotabbed T, Mainardi CL, Hasty KA (1993) Structure-function relationship of human neutrophil collagenase: identification of regions responsible for substrate specificity and general proteinase activity. Proc Natl Acad Sci USA 90: 2569–2573
Howard EW, Banda MJ (1991) Binding of tissue inhibitor of metalloproteinases 2 to two distinct sites on human 72-kDa gelatinase. Identification of a stabilization site. J Biol Chem 266: 17972–17977
Howard EW, Bullen EC, Banda MJ (1991a) Preferential inhibition of 72- and 92-kDa gelatinases by tissue inhibitor of metalloproteinases-2. J Biol Chem 266: 13070–13075
Howard EW, Bullen EC, Banda MJ (1991b) Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases-2. J Biol Chem 266: 13064–13069
Kane SE, Gottesman MM (1990) The role of cathepsin L in malignant transformation. Semin Cancer Biol 1: 127–136
Karelina TV, Goldberg GI, Eisen AZ (1994) Matrilysin (PUMP) correlates with dermal invasion during appendageal development and cutaneous neoplasia. J Invest Dermatol 103: 482–487
Kawami H, Yoshida K, Ohsaki A, Kuroi K, Nishiyama M, Toge T (1993) Stromelysin-3 mRNA expression and malignancy: Comparison with clinicopathological features and type IV collagenase mRNA expression in breast tumors. Anticancer Res 13: 2319–2324
Khokha R, Waterhouse P, Yagel S, Lala P, Overall C, Norton G, Denhardt D (1989) Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science 244: 947–950
Khokha R, Zimmer MJ, Wilson SM, Chambers AF (1992) Up-regulation of TIMP-1 expression in B16–F10 melanoma cells suppresses their metastatic ability in chick embryo. Clin Exp Metastasis 10: 365–370
Knduper V, Murphy G, Tschesche H (1994) Neutrophil procollagenase can be activated by stromelysin-2. Ann NY Acad Sci 732: 367–368
Knduper V, Wilhelm SM, Seperack PK, DeClerck YA, Langley KE, Osthues A, Tschesche H (1993) Direct activation of human neutrophil procollagenase by recombinant stromelysin. Biochem J 295: 581–586
Koop S, Khokha R, Schmidt EE, MacDonald IC, Morris VL, Chambers AF, Groom AC (1994) Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. Cancer Res 54: 4791–4797
Kossakowska AE, Urbanski SJ, Watson A, Hayden LJ, Edwards DR (1993) Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas. Oncol Res 5: 19–28
Leco KJ, Khokha R, Pavloff N, Hawkes SP, Edwards DR (1994) Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 269: 9352–9360
Lefebvre O, Wolf C, Limacher J-M, Hutin P, Wendling C, LeMeur M, Basset P, Rio M-C (1992) The breast cancer-associated stromelysin-3 gene is expressed during mouse mammary gland apoptosis. J Cell Biol 119: 997–1002
Liotta L (1986) Tumor invasion and metastasis — role of the extracellular matrix: Rhoads Memorial Lecture. Cancer Res 46: 1–7
Liotta LA, Steeg PS, Stetler-Stevenson WG (1991) Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327–336
Lovejoy B, Cleasby A, Hassell AM, Longley K, Luther MA, Weigl D, McGeehan G, McElroy AB, Drewry D, Lambert MH, Jordan SR (1994) Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor. Science 263: 375–377.
Majmudar G, Nelson BR, Jensen TC, Johnson TM (1994a) Increased expression of matrix metallo-proteinase-3 (stromelysin-1) in cultured fibroblasts and basal cell carcinomas of nevoid basal cell carcinoma syndrome. Mol Carcinog 11: 29–33.
Majmudar G, Nelson BR, Jensen TC, Voorhees JJ, Johnson TM (1994b) Increased expression of stromelysin-3 in basal cell carcinomas. Mol Carcinog 9: 17–23.
Marcotte PA, Kozan IM, Dorwin SA, Ryan JM (1992) The matrix metalloproteinase pump-1 catalyzes formation of low molecular weight (pro)urokinase in cultures of normal human kidney cells. J Biol Chem 267: 13803–13806.
Matrisian L, Glaichenhaus N, Gesnel M, Breathnach R (1985) Epidermal growth factor and oncogenes induce transcription of the same cellular mRNA in rat fibroblasts. EMBO J 4: 1435–1440.
Matrisian LM (1992) The matrix-degrading metalloproteinases. Bioessays 14: 455–463.
Matrisian LM, Hogan BLM (1990) Growth factor-regulated proteases and extracellular matrix remodeling during mammalian development. Curr Top Dev Biol 24: 219–259.
McDonnell S, Navre M Jr, Coffey RJ, Matrisian LM (1991) Expression and localization of the matrix metalloproteinase PUMP-1 (MMP-7) in human gastric and colon carcinomas. Mol Carcinog 4: 527–533.
Mignatti P, Robbins E, Rifkin DB (1986) Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell 47: 487–498.
Miller EJ, Harris ED Jr, Chung E, Finch JE Jr, McCroskery PA, Butler WT (1976) Cleavage of type II and III collagens with mammalian collagenase: sité of cleavage and primary structure at the NH2- terminal portion of the smaller fragment released from both collagens. Biochemistry 15: 787–792.
Miyazaki K, Hattori Y, Umenishi F, Yasumitsu H, Umeda M (1990) Purification and characterization of extracellular matrix-degrading metalloproteinase, matrin (pump-1), secreted from human rectal carcinoma cell line. Cancer Res 50: 7758–7764.
Moll UM, Lane B, Zucker S, Suzuki K, Nagase H (1990) Localization of collagenase at the basal plasma membrane of a human pancreatic carcinoma cell line. Cancer Res 50: 6995–7002.
Montgomery AMP, Mueller BM, Reisfeld RA, Taylor SM, DeClerck YA (1994) Effect of tissue inhibitor of the matrix metalloproteinases- 2 expression on the growth and spontaneous metastasis of a human melanoma cell line. Cancer Res 54: 5467–5473.
Muller D, Quantin B, Gesnel M, Millon-Collard R, Abecassis J, Breathnach R (1988) The collagenase gene family in humans consists of at least four members. Biochem J 253: 187–192.
Muller D, Breathnach R, Engelmann A, Millón R, Bronner G, Flesch H, Dumont P, Eber M, Abecassis J (1991) Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours. Int J Cancer 48: 550–556.
Muller D, Wolf C, Abecassis J, Millón R, Engelmann A, Bronner G, Rouyer N, Rio MC, Eber M, Methlin G (1993) Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas. Cancer Res 53: 165–169.
Murphy G, Cockett Ml, Ward RV, Docherty AJ (1991) Matric metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem J 277: 277–279.
Murphy G, Willenbrock F, Ward RV, Cockett Ml, Eaton D, Docherty AJP (1992) The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases. Biochem J 283: 637–641.
Murphy G, Segain JP, O’Shea M, Cockett M, loannou C, Lefebvre O, Chambón P, Basset P (1993) The 28-kDa N-terminal domain of mouse stromelysin-3 has the general properties of a weak metalloproteinase. J Biol Chem 268: 15435–15441.
Murphy G, Nguyen Q, Cockett Ml, Atkinson SJ, Allan JA, Knight CG, Willenbrock F, Docherty AJP (1994) Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant. J Biol Chem 269: 6632–6636.
Nagase H, Enghild JJ, Suzuki K, Salvesen G (1990) Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases andT4=aminophenyl)mercuric acetate. Biochemistry 29: 5783–5789.
Nakagawa H, Yagihashi S (1994) Expression of type IV collagen and its degrading enzymes in squamous cell carcinoma of lung. Jpn J Cancer Res 85: 934–938.
Nakano A, Tani E, Miyazaki K, Furuyama J, Matsumoto T (1993) Expression of matrilysin and stromelysin in human glioma cells. Biochem Biophys Res Commun 192: 999–1003.
Newell KJ, Witty JP, Rodgers WH, Matrisian LM (1994) Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. Mol Carcinog 10: 199–206.
Nicholson R, Murphy G, Breathnach R (1989) Human and rat malignant-tumor-associated mRNAs encode stromelysin-like metalloproteinases. Biochemistry 28: 5195–5203.
Nicolson G (1991) Molecular mechanisms of cancer metastasis: tumor and host properties and the role of oncogenes and suppressor genes. Curr Opin Oncol 3: 75–92.
Nicolson GL (1989) Metastatic tumor cell interactions with endothelium, basement membrane and tissue. Curr Opin Cell Biol 1: 1009–1019.
Noël AC, Polette M, Lewalle J-M, Munaut C, Emonard HP, Birembaut P, Foidart J-M (1994) Coordinate enhancement of gelatinase A mRNA and activity levels in human fibroblasts in response to breast-adenocarcinoma cells. Int J Cancer 56: 331–336.
Nuovo GJ, MacConnell PB, Simsir A, Valea F, French DL (1995) Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma. Cancer Res 55: 267–275.
Odekon L, Sato Y, Rifkin DB (1992) Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity. J Cell Physiol 150: 258–263.
Ogata Y, Enghild JJ, Nagase H (1992) Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem 267: 3581–3584.
Okada Y, Konomi H, Yada T, Kimata K, Nagase H (1989) Degradation of type IX collagen by matrix metalloproteinase 3 (stromelysin) from human rheumatoid synovial cells. FEBS Lett 244: 473–476.
Okada A, Bellocq J-P, Rouyer N, Chenard M-P, Rio M-C, Chambón P, Basset P (1995) Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast and head and neck carcinomas. Proc Natl Acad Sci USA 92: 2730–2734.
Pajouh M, Nagle R, Breathnach R, Finch J, Brawer M, Bowden G (1991) Expression of metalloproteinase genes in human prostate cancer. J Cancer Res Clin Oncol 117: 144–150.
Park.AJ, Matrisian LM, Keils AF, Pearson R, Yuan Z, Navre M (1991) Mutational analysis of the transin (rat stromelysin) autoinhibitor region demonstrates a role for residues surrounding the “cysteine switch”. J Biol Chem 266: 1584–1590.
Parkins T (1994) Researchers test TIMP-2 as potential tumor terminator. J Natl Cancer Inst 86: 174–175.
Pei D, Weiss SJ (1995) Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 375: 244–247.
Pei D, Majmudar G, Weiss SJ (1994) Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3. J Biol Chem 269: 25849–25855.
Polette M, Clavel C, Muller D, Abecassis J, Binninger I, Birembaut P (1991) Detection of mRNAs encoding collagenase I and stromelysin 2 in carcinomas of the head and neck by in situ hybridization. Invasion Metastasis 11: 76–83.
Powell WC, Knox JD, Navre M, Grogan TM, Kittelson J, Nagle RB, Bowden GT (1993) Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice. Cancer Res 53: 417–422.
Powell WC, Domann R, Nagle RB, Matrisian LM, Bowden GT (1995) Castration induced expression of matrilysin in the rat ventral prostate. Prostate (submitted).
Quantin B, Murphy G, Breathnach R (1989) Pump-1 cDNA codes for a protein with characteristics similar to those of classical collagenase family members. Biochem J 28: 5327–5333.
Rao JS, Steck PA, Mohanam S, Stetler-Stevenson WG, Liotta LA, Sawaya R (1993) Elevated levels of Mr 92,000 type IV collagenase in human brain tumors. Cancer Res 53: 2208–2211.
Rochefort H, Capony F, Garcia M (1990) Cathepsin D: a protease involved in breast cancer metastasis. Cancer Metastasis Rev 9: 321–331.
Rodgers WH, Osteen KG, Matrisian LM, Navre M, Giudice LC, Gorstein F (1993) Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle. Am J Obstet Gynecol 168: 253–260.
Rodgers WH, Matrisian LM, Giudice LC, Dsupin B, Cannon P, Svitek C, Gorstein F, Osteen KG (1994) Patterns of matrix metalloproteinase expression of cycling endometrium imply differential functions and regulation by steroid hormones. J Clin Invest 94: 946–953.
Roebroek AJ, Creemers JW, Ay’oubi TA, van de Ven WJ (1994) Furin-mediated proprotein processing activity: involvement of negatively charged amino acid residues in the substrate binding region. Biochimie 76: 210–216.
Sanchez-Lopez R, Alexander CM, Behrendtsen O, Breathnach R, Werb Z (1993) Role of zinc-binding- and hemopexin domain-encoded sequences in the substrate specificity of collagenase and stromelysin-2 as revealed by chimeric proteins. J Biol Chem 268: 7238–7247.
Santibañez JF, Martínez J (1993) Membrane-associated procollagenase of leukemic cells is activated by urokinase-type plasminogen activator. Leuk Res 17: 1057–1062.
Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61–65.
Schmid TM, Mayne R, Jeffery JJ, Linsenmayer TF (1986) Type X collagen contains two cleavage sites for a vertabrate collagenase. J Biol Chem 261: 4184–4189.
Schnierer S, Kleine T, Gote T, Hillemann A, Knäuper V, Tschesche H (1993) The recombinant catalytic domain of human neutrophil collagenase lacks type 1 collagen substrate specificity. Biochem Biophys Res Commun 191: 319–326.
Schultz RM, Silberman S, Persky B, Bajkowski AS, Carmichael DF (1988) Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16–F10 melanoma cells. Cancer Res 48: 5539–5545.
Seltzer JL, Eisen AZ, Bauer EA, Morris NP, Glanville RW, Burgeson RE (1989) Cleavage of type VII collagen by interstitial collagenase and type IV collagenase (gelatinase) derived from human skin. J Biol Chem 264: 3822–3826.
Senior RM, Griffin GL, Fliszar CJ, Shapiro SD, Goldberg Gl, Welgus HG (1991) Human 92- and 72-kilodalton type IV collagenases are elastases. J Biol Chem 266: 7870–7875.
Shapiro SD, Griffin GL, Gilbert DJ, Jenkins NA, Copeland NG, Welgus HG, Senior RM, Ley TJ (1992) Molecular cloning, chromosomal localization, and bacterial expression of a murine macrophage metalloelastase. J Biol Chem 267: 4664–4671.
Shima I, Sasaguri Y, Kusukawa J, Yamana H, Fujita H, Kakegawa T, Morimatsu M (1992) Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study. Cancer 70: 2747–2753.
Silbiger SM, Jacobsen VL, Cupples RL, Koski RA (1994) Cloning of cDNAs encoding human TIMP-3, a novel member of the tissue inhibitor of metalloproteinase family. Gene 141: 293–297.
Sires Ul, Griffin GL, Broekelmann TJ, Mecham RP, Murphy G, Chung AE, Welgus HG, Senior RM (1993) Degradation of entactin by matrix metalloproteinases. Susceptibility to matrilysin and identification of cleavage sites. J Biol Chem 268: 2069–2074.
Siri A, Knauper V, Veirana N, Caocci F, Murphy G, Zardi L (1995) Different susceptability of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases. J Biol Chem 270: 8650–8654.
Springman E, Angleton E, Birkedal-Hansen H, Van Wart H (1990) Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys 73 active-site zinc complex in latency and a ‘cysteine switch’ mechanism for activation. Proc Natl Acad Sci USA 87: 364–368.
Suzuki K, Enghild JJ, Morodomi T, Salvesen G, Nagase H (1990) Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin) Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl) mercuric acetate. Biochemistry 29: 5783–5789.
Sympson CJ, Alexander CM, Chin JR, Werb Z, Bissell MJ (1993) Transgenic expression of stromelysin from the WAP promoter alters branching morphogenesis during mammary gland development and results in precocious expression of milk genes. Mol Biol Cell 4: 188a.
Sympson CJ, Talhouk RS, Alexander CM, Chin JR, Clift SM, Bissell MJ, Werb Z (1994) Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J Cell Biol 125: 681–693.
Takino T, Sato H, Shinagawa A, Seiki M (1995) Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. J Biol Chem 270: 23013–23020.
Talhouk RS, Bissell MJ, Werb Z (1992) Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J Cell Biol 118: 1271–1282.
Tenniswood MP, Guenette RS, Lakins J, Mooibroek M, Wong P, Welsh J-E (1992) Active cell death in hormone-dependent tissues. Cancer Metastasis Rev 11: 197–220.
Thompson EW, Yu M, Bueno J, Jin L, Maiti SN, Palao-Marco FL, Pulyaeva H, Tamborlane JW, Tirgari R, Wapnir I, Azzam H (1994) Collagen induced MMP-2 activation in human breast cancer. Breast Cancer Res Treat 31: 357–370.
Tremble PM, Damsky CH, Werb Z (1992) Fibronectin fragments, but not intact fibronectin, signaling through the fibronectin receptor induce metalloproteinase gene expression in fibroblasts. Matrix [Suppl] 1: 212–214.
Urbanski SJ, Edwards DR, Maitland A, Leco KJ, Watson A, Kossakowska AE (1992) Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas. Br J Cancer 66: 1188–1194.
Van Wart HE, Birkedal-Hansen H (1990) The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci USA 87: 5578–5582.
Wagner SN, Ruhri C, Kunth K, Holecek BU, Goos M, Hofler H, Atkinson MJ (1992) Expression of stromelysin 3 in the stromal elements of human basal cell carcinoma. Diagn Mol Pathol 1: 200–205.
Ward RV, Atkinson SJ, Reynolds JJ, Murphy G (1994) Cell surface-mediated activation of progelatinase A: demonstration of the involvement of the C-terminal domain of progelatinase A in cell surface binding and activation of progelatinase A by primary fibroblasts. Biochem J 304: 263–269.
Welgus HG, Fliszar CJ, Seltzer JL, Schmid TM, Jeffrey JJ (1990) Differential susceptibility of type X collagen to cleavage by two mammalian interstitial collagenases and 72-kDa type IV collagenase. J Biol Chem 265: 13521–13527.
Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg Gl (1989) SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages [published erratum appears in J Biol Chem 1990 Dec 25; 265(36): 22570]. J Biol Chem 264: 17213–17221.
Will H, Hinzmann B (1995) cDNA sequence and mRNA tissue distribution of novel human matrix metalloproteinase with a potential transmembrane segment. Eur J Biochem 231: 602–608.
Williamson RA, Marston FA, Angal S, Koklitis P, Panico M, Morris HR, Came AF, Smith BJ, Harris TJ, Freedman RB (1990) Disulphide bond assignment in human tissue inhibitor of metalloproteinases (TIMP). Biochem J 268: 267–274.
Windsor LJ, Bodden MK, Birkedal-Hansen B, Engler JA, Birkedal-Hansen H (1994) Mutational analysis of residues in and around the active site of human fibroblast-type collagenase. J Biol Chem 269: 26201–26207.
Witty JP, McDonnell S, Newell KJ, Cannon P, Navre M, Tressler RJ, Matrisian LM (1994) Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo. Cancer Res 54: 4805–4812.
Witty JP, Wright J, Matrisian LM (1995a) Mammary epithelial cell proliferation and premature alveolar development in virgin transgenic mice expressing the metalloproteinase stromelysin. Mol Biol Cell (Submitted).
Witty JP, Lempka T, Coffey RJ Jr, Matrisian LM (1995b) Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis. Cancer Res 55: 1401–1406.
Woessner JF Jr (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5: 2145–2154.
Wolf C, Chenard MP, Durand de Grossouvre P, Bellocq JP, Chambón P, Basset P (1992) Breast-cancer-associated stromelysin-3 gene is expressed in basal cell carcinoma and during cutaneous wound healing. J Invest Dermatol 99: 870–872.
Wright JH, McDonnell S, Portella G, Bowden GT, Balmain A, Matrisian LM (1994) A switch from stromal to tumor cell expression of stromelysin-1 mRNA associated with the conversion of squamous to spindle carcinomas during mouse skin tumor progression. Mol Carcinog 10: 207–215.
Yamamoto H, Itoh F, Hinoda Y, Senota A, Yoshimoto M, Nakamura H, Imai K, Yachi A (1994) Expression of matrilysin mRNA in colorectal adenomas and its induction by truncated fibronectin. Biochem Biophys Res Commun 201: 657–664.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Powell, W.C., Matrisian, L.M. (1996). Complex Roles of Matrix Metalloproteinases in Tumor Progression. In: Günthert, U., Birchmeier, W. (eds) Attempts to Understand Metastasis Formation I. Current Topics in Microbiology 213/I and Immunology, vol 213/1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-61107-0_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-61107-0_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64697-3
Online ISBN: 978-3-642-61107-0
eBook Packages: Springer Book Archive